Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1988 Nov;95(3):777–782. doi: 10.1111/j.1476-5381.1988.tb11704.x

Studies of the effects of subacute treatment with N-(cyclopropylmethyl)-19-isopentylnororvinol (M320) on timing of parturition in the rat.

R G Evans 1, G E Rice 1, J E Olley 1
PMCID: PMC1854236  PMID: 3207993

Abstract

1. Administration of 10 micrograms kg-1 of the long lasting potent kappa- and weaker mu-opioid agonist N-(cyclopropylmethyl)-19-isopentylnororvinol (M320) twice daily from day 20 of gestation prolonged the internal gestation period of the rat and retarded the development of the offspring in the perinatal period. 2. The capacities of myometrial, placental and cervical tissues to produce prostaglandin E2 (PGE2) were not affected by M320 treatment. 3. During the period in which parturition normally occurred in saline-treated rats, foetal pituitary levels of immunoreactive oxytocin (ir-OXY) but not immunoreactive arginine-vasopressin (ir-AVP) were greater in M320-compared to saline-treated animals. Following the completion of parturition, foetal pituitary ir-OXY and ir-AVP levels continued to rise in saline-treated rats, but fell dramatically in rats treated subacutely with M320. 4. These data indicate that subacute treatment with M320 may inhibit foetal oxytocin release at term. This foetal OXY release may be a stimulus for the initiation of labour.

Full text

PDF
782

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrahams J. M., Boura A. L., Evans R. G., Johnston C. I., Olley J. E. The effects of N-(cyclopropylmethyl)-19-isopentylnororvinol (M320), a potent agonist at kappa- and mu-opiate receptors, on urine excretion of rats. Br J Pharmacol. 1986 Dec;89(4):759–767. doi: 10.1111/j.1476-5381.1986.tb11180.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aiken J. W. Aspirin and indomethacin prolong parturition in rats: evidence that prostaglandins contribute to expulsion of fetus. Nature. 1972 Nov 3;240(5375):21–25. doi: 10.1038/240021a0. [DOI] [PubMed] [Google Scholar]
  3. Alexandrova M., Soloff M. S. Oxytocin receptors and parturition. III. Increases in estrogen receptor and oxytocin receptor concentrations in the rat myometrium during prostaglandin F2 alpha-induced abortion. Endocrinology. 1980 Mar;106(3):739–743. doi: 10.1210/endo-106-3-739. [DOI] [PubMed] [Google Scholar]
  4. Boer K., Dogterom J., Pronker H. F. Pituitary content of oxytocin, vasopressin and alpha-melanocyte-stimulating hormone in the fetus of the rat during labour. J Endocrinol. 1980 Aug;86(2):221–229. doi: 10.1677/joe.0.0860221. [DOI] [PubMed] [Google Scholar]
  5. Boura A. L., Fitzgerald A. E. The pharmacology of N-(cyclopropylmethyl)-19-isopentylnororvinol hydrochloride. A potent and long lasting central depressant. Br J Pharmacol Chemother. 1966 Feb;26(2):307–321. doi: 10.1111/j.1476-5381.1966.tb01910.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chester R., Dukes M., Slater S. R., Walpole A. L. Delay of parturition in the rat by anti-inflammatory agents which inhibit the biosynthesis of prostaglandins. Nature. 1972 Nov 3;240(5375):37–38. doi: 10.1038/240037a0. [DOI] [PubMed] [Google Scholar]
  7. Clarke G., Wood P., Merrick L., Lincoln D. W. Opiate inhibition of peptide release from the neurohumoral terminals of hypothalamic neurones. Nature. 1979 Dec 13;282(5740):746–748. doi: 10.1038/282746a0. [DOI] [PubMed] [Google Scholar]
  8. Fuchs A. R., Poblete V. F., Jr Oxytocin and uterine function in pregnant and parturient rats. Biol Reprod. 1970 Jun;2(3):387–400. doi: 10.1095/biolreprod2.3.387. [DOI] [PubMed] [Google Scholar]
  9. Hurst P. R., Peplow P. V. Impairment of protein synthesis in the rat uterus following intrauterine delivery of indomethacin. Br J Pharmacol. 1986 Sep;89(1):199–205. doi: 10.1111/j.1476-5381.1986.tb11136.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jeremy J. Y., Dandona P. RU486 antagonizes the inhibitory action of progesterone on prostacyclin and thromboxane A2 synthesis in cultured rat myometrial explants. Endocrinology. 1986 Aug;119(2):655–660. doi: 10.1210/endo-119-2-655. [DOI] [PubMed] [Google Scholar]
  11. Kumaresan P., Kagan A., Glick S. M. Oxytocin antibody and lactation and parturition in rats. Nature. 1971 Apr 16;230(5294):468–469. doi: 10.1038/230468a0. [DOI] [PubMed] [Google Scholar]
  12. Kuriyama H., Suzuki H. Effects of prostaglandin E2 and oxytocin on the electrical activity of hormone-treated and pregnant rat myometria. J Physiol. 1976 Sep;260(2):335–349. doi: 10.1113/jphysiol.1976.sp011518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rice G. E., Thorburn G. D. Subcellular localization of oxytocin in the ovine corpus luteum. Can J Physiol Pharmacol. 1985 Apr;63(4):309–314. doi: 10.1139/y85-056. [DOI] [PubMed] [Google Scholar]
  14. Rice G. E., Wong M. H., Ralph M. M., Thorburn G. D. Ovine allantoic fluid inhibition of prostaglandin synthesis in cotyledonary microsomes. J Endocrinol. 1987 Aug;114(2):295–300. doi: 10.1677/joe.0.1140295. [DOI] [PubMed] [Google Scholar]
  15. Schriefer J. A., Lewis P. R., Miller J. W. Effect of dopamine on length of gestation and on the release of fetal oxytocin in rats. J Pharmacol Exp Ther. 1980 Mar;212(3):431–434. [PubMed] [Google Scholar]
  16. Schriefer J. A., Lewis P. R., Miller J. W. Role of fetal oxytocin in parturition in the rat. Biol Reprod. 1982 Sep;27(2):362–368. doi: 10.1095/biolreprod27.2.362. [DOI] [PubMed] [Google Scholar]
  17. Strauss J. F., 3rd, Sokoloski J., Caploe P., Duffy P., Mintz G., Stambaugh R. L. On the role of prostaglandins in parturition in the rat. Endocrinology. 1975 Apr;96(4):1040–1043. doi: 10.1210/endo-96-4-1040. [DOI] [PubMed] [Google Scholar]
  18. Walsh J. R., Niall H. D. Use of an octadecylsilica purification method minimizes proteolysis during isolation of porcine and rat relaxins. Endocrinology. 1980 Oct;107(4):1258–1260. doi: 10.1210/endo-107-4-1258. [DOI] [PubMed] [Google Scholar]
  19. Woods R. L., Johnston C. I. Contribution of vasopressin to the maintenance of blood pressure during dehydration. Am J Physiol. 1983 Nov;245(5 Pt 1):F615–F621. doi: 10.1152/ajprenal.1983.245.5.F615. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES